TY - JOUR
T1 - Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians
AU - Kunneman, M.
AU - Pieterse, A. H.
AU - Stiggelbout, A. M.
AU - Nout, R. A.
AU - Kamps, M.
AU - Lutgens, L. C. H. W.
AU - Paulissen, J.
AU - Mattheussens, O. J. A.
AU - Kruitwagen, R. F. P. M.
AU - Creutzberg, C. L.
PY - 2014/8/12
Y1 - 2014/8/12
N2 - Background: Vaginal brachytherapy (VBT) in high-intermediate-risk endometrial cancer (EC) provides a significant reduction in the risk of local cancer recurrence, but without survival benefit and with increased mucosal atrophy. Five-year local control is estimated to be similar for VBT and a watchful waiting policy (WWP), in which patients receive VBT combined with external radiation in case of a recurrence. Our aim was to assess treatment preferences of EC patients and clinicians regarding VBT and WWP, and to evaluate their preferred and perceived involvement in treatment decision making. Methods: Interviews were held with 95 treated EC patients. The treatment trade-off method was used to assess the minimally desired benefit from VBT in local control. Patients' preferred and perceived involvement in decision making were assessed using a questionnaire. Seventy-seven clinicians completed a questionnaire assessing their minimally desired benefit and preferred involvement in decision making. Results: Minimally desired benefit of VBT was significantly lower for patients than for clinicians (median 0 vs 8%, P
AB - Background: Vaginal brachytherapy (VBT) in high-intermediate-risk endometrial cancer (EC) provides a significant reduction in the risk of local cancer recurrence, but without survival benefit and with increased mucosal atrophy. Five-year local control is estimated to be similar for VBT and a watchful waiting policy (WWP), in which patients receive VBT combined with external radiation in case of a recurrence. Our aim was to assess treatment preferences of EC patients and clinicians regarding VBT and WWP, and to evaluate their preferred and perceived involvement in treatment decision making. Methods: Interviews were held with 95 treated EC patients. The treatment trade-off method was used to assess the minimally desired benefit from VBT in local control. Patients' preferred and perceived involvement in decision making were assessed using a questionnaire. Seventy-seven clinicians completed a questionnaire assessing their minimally desired benefit and preferred involvement in decision making. Results: Minimally desired benefit of VBT was significantly lower for patients than for clinicians (median 0 vs 8%, P
U2 - 10.1038/bjc.2014.322
DO - 10.1038/bjc.2014.322
M3 - Article
C2 - 24921911
SN - 0007-0920
VL - 111
SP - 674
EP - 679
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 4
ER -